Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Trump’s New Global Health Initiative Could Transform the AIDS Fight
World AIDS Day serves as a poignant reminder of those lost to the HIV virus while highlighting our nation’s historic efforts to combat this preventable and treatable disease. The day encourages reflection on progress made and the work still needed to eradicate AIDS.
Nearly 25 years ago, the United States, with broad bipartisan support, launched the most ambitious global HIV/AIDS initiative in history, known as PEPFAR. This program has been credited with saving over 26 million lives across some of the world’s most impoverished nations, particularly in sub-Saharan Africa, where HIV/AIDS rates are highest.
PEPFAR has also served to advance U.S. interests globally. By demonstrating our nation’s values of compassion and human rights, it has helped combat instability while promoting healthier communities which ultimately lessens the burden on U.S. foreign policy.
During my time as an appointee under President Donald Trump at the U.S. Department of State, I acted as the Congressional Liaison Officer for PEPFAR. In 2018, I collaborated with the White House in securing the reauthorization of this vital program through the Republican-controlled Congress. The law was ultimately signed by President Trump, reaffirming the United States’ commitment to global health.
At that pivotal moment, PEPFAR adopted a localized approach to its operations, enhancing efficiency and maximizing the impact of U.S. taxpayer dollars. This strategy received accolades from organizations like Project 2025, suggesting it as a model for future global development programs.
Over the past year, we have witnessed both encouraging signs and serious challenges. Although an initial pause on foreign aid raised concerns, the swift response ensured PEPFAR continued its operations. However, the dismantling of USAID, one of PEPFAR’s implementing agencies, raised fears about service disruption on the ground, which impacted our ability to fully realize the program’s goals.
Under the leadership of President Trump, Secretary Rubio, and Senior State Department official Jeremy Lewin, alongside Gilead Sciences, the U.S. has begun distributing a new groundbreaking drug. This innovative medication is administered twice a year, offering a dual benefit: it prevents the spread of HIV/AIDS while serving as an effective antiretroviral treatment for those already infected.
This moment marks a significant leap forward in the global fight against HIV/AIDS, fueling optimism that we can end AIDS by 2030. President Trump has articulated a bold ambition to eliminate mother-to-child transmission of HIV within three years, reaffirming his dedication to this critical public health issue.
PEPFAR is part of a larger triad of global health initiatives, which also includes the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the United Nations Joint Program on HIV/AIDS, known as UNAIDS. Just recently, Jeremy Lewin announced a substantial $4.6 billion pledge from the U.S. to the Global Fund, a commitment that will be strengthened through matching contributions from other countries and donors.
In his remarks, Lewin emphasized the optimism in American healthcare leadership’s future. The State Department recently revealed an “American First” global health strategy that reaffirms our commitment to advancing global health while implementing necessary reforms to improve effectiveness.
Despite these advances, UNAIDS, a crucial organization for ensuring accountability, data collection, and coordination, faces significant funding shortfalls. To maintain essential operations and ensure effective use of every dollar, UNAIDS urgently requires $50 million in support. While this figure may seem small relative to overall commitments, it is critical for maximizing the impact of global health efforts.
Progress continues in the fight against global AIDS through innovative approaches, with the private sector playing an increasingly important role. President Trump made history by being the first sitting president to call for an end to AIDS in his 2019 State of the Union Address. The world pays attention when he speaks, putting the spotlight on the possibility of eradicating AIDS.
As the U.S. prepares to host significant international events like the World Cup and the Olympics, we have an opportunity to promote the message of ending AIDS on a grand scale. This is a vision that President Trump has championed, and it can resonate globally.
The alignment of rhetoric and reality is crucial. If this administration can deliver meaningful outcomes, resulting in the saving of millions of lives, the achievement could be worthy of the highest accolades, including the Nobel Peace Prize. Such recognition would stand as a testament to the lasting legacy of President Trump’s leadership in global health.
